These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 15635801)
1. [Cytokines in cardiovascular diseases. Role in pathogenesis, effect on prognosis, therapeutic perspectives]. Penicka M; Gregor P Vnitr Lek; 2000 Jul; 46(7):398-402. PubMed ID: 15635801 [TBL] [Abstract][Full Text] [Related]
2. Clinical implications of cytokines in the critical-care unit. El-Menyar AA; Davidson BL Expert Rev Cardiovasc Ther; 2009 Jul; 7(7):835-45. PubMed ID: 19589119 [TBL] [Abstract][Full Text] [Related]
3. [Proinflammatory cytokines in cardiovascular diseases as potential therapeutic target]. Bielecka-Dabrowa A; Wierzbicka M; Goch JH Wiad Lek; 2007; 60(9-10):433-8. PubMed ID: 18350717 [TBL] [Abstract][Full Text] [Related]
5. [The role of cytokines in pathogenesis of cardiovascular disorders]. Mizia-Stec K; Mandecki T; Jastrzebska-Maj E Przegl Lek; 1999; 56(4):292-8. PubMed ID: 10494167 [TBL] [Abstract][Full Text] [Related]
6. Endothelial progenitor cells: new perspectives and applications in cardiovascular therapies. Marsboom G; Janssens S Expert Rev Cardiovasc Ther; 2008 Jun; 6(5):687-701. PubMed ID: 18510485 [TBL] [Abstract][Full Text] [Related]
7. [The role of cytokines in cardiovascular diseases]. Kuliczkowski W Pol Merkur Lekarski; 2001 Jul; 11(61):60-4. PubMed ID: 11579835 [TBL] [Abstract][Full Text] [Related]
8. [Drugs used in cardiovascular diseases and cytokines]. Andrzejczak D; Górska D Wiad Lek; 2006; 59(3-4):232-7. PubMed ID: 16813270 [TBL] [Abstract][Full Text] [Related]
9. [Stem cell therapy for cardiovascular diseases. Experiences in Düsseldorf]. Schannwell CM Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 8():S274-9. PubMed ID: 19085806 [TBL] [Abstract][Full Text] [Related]
10. Cytokines and myocardial dysfunction: state of the art. El-Menyar AA J Card Fail; 2008 Feb; 14(1):61-74. PubMed ID: 18226775 [TBL] [Abstract][Full Text] [Related]
12. The anti-inflammatory effect of exercise: its role in diabetes and cardiovascular disease control. Pedersen BK Essays Biochem; 2006; 42():105-17. PubMed ID: 17144883 [TBL] [Abstract][Full Text] [Related]
13. Cardiovascular risk and rheumatoid arthritis: from mechanisms of atherosclerosis to therapeutic approach. Jurcuţ C; Jurcuţ R; Tănăsescu C Rom J Intern Med; 2004; 42(4):659-69. PubMed ID: 16366138 [TBL] [Abstract][Full Text] [Related]
14. Actions and therapeutic potential of G-CSF and GM-CSF in cardiovascular disease. Kovacic JC; Muller DW; Graham RM J Mol Cell Cardiol; 2007 Jan; 42(1):19-33. PubMed ID: 17109881 [TBL] [Abstract][Full Text] [Related]
15. Role of angiogenesis in cardiovascular disease: a critical appraisal. Khurana R; Simons M; Martin JF; Zachary IC Circulation; 2005 Sep; 112(12):1813-24. PubMed ID: 16172288 [TBL] [Abstract][Full Text] [Related]
16. [Vascular medicine: the near future]. De Sensi F; De Siati L; Cosentino F Recenti Prog Med; 2006 Dec; 97(12):711-8. PubMed ID: 17252729 [TBL] [Abstract][Full Text] [Related]
17. Myocardial ischemia/reperfusion-injury, a clinical view on a complex pathophysiological process. Moens AL; Claeys MJ; Timmermans JP; Vrints CJ Int J Cardiol; 2005 Apr; 100(2):179-90. PubMed ID: 15823623 [TBL] [Abstract][Full Text] [Related]
18. Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms. Loppnow H; Werdan K; Buerke M Innate Immun; 2008 Apr; 14(2):63-87. PubMed ID: 18713724 [TBL] [Abstract][Full Text] [Related]
19. [Uric acid as a marker of pathophysiological mechanisms in patients with cardiovascular disease]. Calberg MJ; Kjøller E Ugeskr Laeger; 2005 Oct; 167(40):3771-4. PubMed ID: 16221391 [TBL] [Abstract][Full Text] [Related]